Search Glossary & FAQs
Popular Searches: Biosimilars, biopharmaceuticals, characterization
Work closely with BioPharmaSpec biosimilar experts to plan your biosimilar testing strategies, including full structural characterization and comparability of the originator/ reference product and your biosimilar.
BioPharmaSpec scientists can provide you with quality structural, biophysical and physicochemical analytical data to accelerate the development of your biopharmaceutical.
BioPharmaSpec will develop a MS based HCP method for your product, to quantitate HCP levels throughout your process and in your final product.
Frequently Asked Questions
Speak To An Expert
Our scientists pioneered the now well-accepted strategies of mass spectrometric peptide mapping, disulfide bridge assignment and characterization of important glycosylation.
Find out how we can solve your analytical challenges.
BioPharmaSpec Glossary
- a-ion
- AAV (Adeno Associated Viruses)
- Accurate mass
- Alkylation
- Alpha helix
- Amino acids
- ANDA
- Antibody Drug Conjugate (ADC)
- API
- Atomic Mass Unit (amu)
- Average mass
- Dalton (Da)
- Dalton (Da)
- De-novo sequencing
- Deamidation
- Deoxyribonucleic acid (DNA)
- Disulfide bridges
- DNA Replication
- Downstream Processing (DSP)
- Drug Product (DP)
- Drug Substance (DS)
- Drug-to-Antibody Ratio (DAR)
- Gene
- Gene (DNA) sequencing
- Gene Expression
- Gene Therapy
- Genetic engineering
- Genome
- Genomics
- Glycation
- Glycosylation
- Peptide
- Peptide mapping
- Phosphorylation
- Polyethylene glycol (PEG)
- Post Translational Modification (PTM)
- Process Related Impurities
OUR LAB TEAM